Načítá se...

Metabolic Tumor Volume as a Prognostic Imaging-Based Biomarker for Head and Neck Cancer—Pilot Results from RTOG 0522

PURPOSE: To evaluate candidate FDG-PET/CT imaging biomarkers for head and neck chemoradiotherapy outcomes in the cooperative group trial setting. METHODS: RTOG 0522 patients consenting to a secondary FDG-PET/CT sub-study were serially imaged at baseline and 8 weeks following radiation. Maximum stand...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Radiat Oncol Biol Phys
Hlavní autoři: Schwartz, David L., Harris, Jonathan, Yao, Min, Rosenthal, David I., Opanowski, Adam, Levering, Anthony, (R)(CT)(MR), RT, Ang, K. Kian, Trotti, Andy M., Garden, Adam S., Jones, Christopher U., Harari, Paul, Foote, Robert, Holland, John, Zhang, Qiang, Le, Quynh-Thu
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4672942/
https://ncbi.nlm.nih.gov/pubmed/25752384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2014.12.023
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!